Congratulations!

[Valid RSS] This is a valid RSS feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

Source: http://www.mayoclinicproceedings.org/current.rss

  1. <?xml version="1.0" encoding="UTF-8"?>
  2. <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  3.         xmlns="http://purl.org/rss/1.0/"
  4.         xmlns:dc="http://purl.org/dc/elements/1.1/"
  5.         xmlns:dcterms="http://purl.org/dc/terms/"
  6.         xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
  7.         xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  8.         xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# uri:atypon.com:cms:schema:rdf.xsd">
  9.   <channel rdf:about="https://www.mayoclinicproceedings.org/issues?publicationCode=jmcp&amp;rss=yes">
  10.      <title>Mayo Clinic Proceedings</title>
  11.      <description>Mayo Clinic Proceedings RSS feed. </description>
  12.      <link>https://www.mayoclinicproceedings.org/issues?publicationCode=jmcp&amp;rss=yes</link>
  13.      <dc:publisher>Elsevier Inc.</dc:publisher>
  14.      <dc:language>en</dc:language>
  15.      <dc:rights>© 2024 Published by Elsevier Inc. All rights reserved.</dc:rights>
  16.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  17.      <prism:issn>0025-6196</prism:issn>
  18.      <prism:publicationDate>2024-04-16-07:00</prism:publicationDate>
  19.      <prism:copyright>© 2024 Published by Elsevier Inc. All rights reserved.</prism:copyright>
  20.      <prism:rightsAgent>permissionshelpdesk@elsevier.com</prism:rightsAgent>
  21.      <items>
  22.         <rdf:Seq>
  23.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00610-9/fulltext?rss=yes"/>
  24.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00037-5/fulltext?rss=yes"/>
  25.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00466-4/fulltext?rss=yes"/>
  26.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00035-1/fulltext?rss=yes"/>
  27.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00602-X/fulltext?rss=yes"/>
  28.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00568-2/fulltext?rss=yes"/>
  29.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00367-1/fulltext?rss=yes"/>
  30.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00358-0/fulltext?rss=yes"/>
  31.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00453-6/fulltext?rss=yes"/>
  32.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00412-3/fulltext?rss=yes"/>
  33.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00451-2/fulltext?rss=yes"/>
  34.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00414-7/fulltext?rss=yes"/>
  35.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00413-5/fulltext?rss=yes"/>
  36.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00603-1/fulltext?rss=yes"/>
  37.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00572-4/fulltext?rss=yes"/>
  38.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00026-0/fulltext?rss=yes"/>
  39.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00570-0/fulltext?rss=yes"/>
  40.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00480-9/fulltext?rss=yes"/>
  41.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00359-2/fulltext?rss=yes"/>
  42.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00341-5/fulltext?rss=yes"/>
  43.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00365-8/fulltext?rss=yes"/>
  44.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00364-6/fulltext?rss=yes"/>
  45.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00469-X/fulltext?rss=yes"/>
  46.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00407-X/fulltext?rss=yes"/>
  47.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00366-X/fulltext?rss=yes"/>
  48.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00304-X/fulltext?rss=yes"/>
  49.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00356-7/fulltext?rss=yes"/>
  50.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00373-7/fulltext?rss=yes"/>
  51.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00283-5/fulltext?rss=yes"/>
  52.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00347-6/fulltext?rss=yes"/>
  53.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00305-1/fulltext?rss=yes"/>
  54.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00144-7/fulltext?rss=yes"/>
  55.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00112-5/fulltext?rss=yes"/>
  56.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00111-3/fulltext?rss=yes"/>
  57.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00110-1/fulltext?rss=yes"/>
  58.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00103-4/fulltext?rss=yes"/>
  59.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00102-2/fulltext?rss=yes"/>
  60.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00101-0/fulltext?rss=yes"/>
  61.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00098-3/fulltext?rss=yes"/>
  62.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00097-1/fulltext?rss=yes"/>
  63.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00084-3/fulltext?rss=yes"/>
  64.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00050-8/fulltext?rss=yes"/>
  65.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00034-X/fulltext?rss=yes"/>
  66.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00025-9/fulltext?rss=yes"/>
  67.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00607-9/fulltext?rss=yes"/>
  68.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00554-2/fulltext?rss=yes"/>
  69.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00527-X/fulltext?rss=yes"/>
  70.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00061-7/fulltext?rss=yes"/>
  71.         </rdf:Seq>
  72.      </items>
  73.   </channel>
  74.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00610-9/fulltext?rss=yes">
  75.      <title>Blood Calcium, Genetic Risk, and Risk of Incident Kidney Stone: A Population-Based Cohort Study</title>
  76.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00610-9/fulltext?rss=yes</link>
  77.      <description>To investigate the association between blood calcium concentration and incident kidney stone as well as to assess the role played by genetic susceptibility.</description>
  78.      <dc:title>Blood Calcium, Genetic Risk, and Risk of Incident Kidney Stone: A Population-Based Cohort Study</dc:title>
  79.      <dc:creator>Xi Cao, Si Li, Yunlong Guan, Zhonghe Shao, Minghui Jiang, Miao Wang, Xingjie Hao</dc:creator>
  80.      <dc:identifier>10.1016/j.mayocp.2023.12.009</dc:identifier>
  81.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  82.      <dc:date>2024-04-16</dc:date>
  83.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  84.      <prism:publicationDate>2024-04-16</prism:publicationDate>
  85.      <prism:section>Original Article</prism:section>
  86.   </item>
  87.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00037-5/fulltext?rss=yes">
  88.      <title>Predicting Primary Care Physician Burnout From Electronic Health Record Use Measures</title>
  89.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00037-5/fulltext?rss=yes</link>
  90.      <description>To evaluate the ability of routinely collected electronic health record (EHR) use measures to predict clinical work units at increased risk of burnout and potentially most in need of targeted interventions.</description>
  91.      <dc:title>Predicting Primary Care Physician Burnout From Electronic Health Record Use Measures</dc:title>
  92.      <dc:creator>Daniel Tawfik, Mohsen Bayati, Jessica Liu, Liem Nguyen, Amrita Sinha, Thomas Kannampallil, Tait Shanafelt, Jochen Profit</dc:creator>
  93.      <dc:identifier>10.1016/j.mayocp.2024.01.005</dc:identifier>
  94.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  95.      <dc:date>2024-04-03</dc:date>
  96.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  97.      <prism:publicationDate>2024-04-03</prism:publicationDate>
  98.      <prism:section>Original article</prism:section>
  99.   </item>
  100.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00466-4/fulltext?rss=yes">
  101.      <title>Incident Diuretic Use and Subsequent Risk of Bone Fractures</title>
  102.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00466-4/fulltext?rss=yes</link>
  103.      <description>To investigate the association of incident use of diuretics with subsequent risk of incident bone fractures.</description>
  104.      <dc:title>Incident Diuretic Use and Subsequent Risk of Bone Fractures</dc:title>
  105.      <dc:creator>Keiichi Sumida, Prabin Shrestha, Yamini Mallisetty, Satya Surbhi, Fridtjof Thomas, Elani Streja, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy</dc:creator>
  106.      <dc:identifier>10.1016/j.mayocp.2023.09.018</dc:identifier>
  107.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  108.      <dc:date>2024-04-03</dc:date>
  109.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  110.      <prism:publicationDate>2024-04-03</prism:publicationDate>
  111.      <prism:section>Original article</prism:section>
  112.   </item>
  113.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00035-1/fulltext?rss=yes">
  114.      <title>Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women</title>
  115.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00035-1/fulltext?rss=yes</link>
  116.      <description>To quantify the burden of metabolic dysfunction–associated steatotic liver disease (MASLD) and related metabolic disorders in premenopausal women.</description>
  117.      <dc:title>Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women</dc:title>
  118.      <dc:creator>Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Siwanart Kongarin, Karan Srisurapanont, Phakkamon Pingwang, Nonlawan Songmueang, Chalida Nonthasoot, Worapaka Manosroi, Surakit Nathisuwan, Fang Li, Ju Dong Yang, Vincent L. Chen, Donghee Kim, Mazen Noureddin, Daniel Q. Huang, Karn Wijarnpreecha</dc:creator>
  119.      <dc:identifier>10.1016/j.mayocp.2023.12.025</dc:identifier>
  120.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  121.      <dc:date>2024-03-28</dc:date>
  122.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  123.      <prism:publicationDate>2024-03-28</prism:publicationDate>
  124.      <prism:section>Original article</prism:section>
  125.   </item>
  126.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00602-X/fulltext?rss=yes">
  127.      <title>Immunogammopathy Maculopathy</title>
  128.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00602-X/fulltext?rss=yes</link>
  129.      <description>A male in his mid-50s presented with painless and progressive blurred vision on his left eye for several weeks. The patient denied any comorbidities and past ophthalmic history. Best corrected visual acuity was 20/20 on his right eye and 20/40 on the left eye. The right eye examination was unremarkable. The left eye showed vascular and macular alterations (Figure 1). The patient underwent complete multimodal retinal imaging, including a normal indocyanine green angiography. Given this presentation, differentials included retinal, systemic, optic nerve, and inflammatory and neoplastic diseases.</description>
  130.      <dc:title>Immunogammopathy Maculopathy</dc:title>
  131.      <dc:creator>Luca Goncalves, Jose Pulido</dc:creator>
  132.      <dc:identifier>10.1016/j.mayocp.2023.12.002</dc:identifier>
  133.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  134.      <dc:date>2024-03-28</dc:date>
  135.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  136.      <prism:publicationDate>2024-03-28</prism:publicationDate>
  137.      <prism:section>Medical Image</prism:section>
  138.   </item>
  139.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00568-2/fulltext?rss=yes">
  140.      <title>Laryngeal Amyloidosis</title>
  141.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00568-2/fulltext?rss=yes</link>
  142.      <description>Amyloidosis is a disease characterized by abnormal extracellular deposition of fibrillar proteins in tissues that creates a chronic inflammatory response leading to local tissue injury. The larynx is estimated to be involved in up to 15% of all amyloidosis cases.1 Symptoms of amyloidosis are nonspecific, and the diagnosis is determined by the severity and laryngeal site involved. It typically presents with dysphonia, but patients can also have dyspnea, stridor, odynophagia, cough, and hemoptysis.</description>
  143.      <dc:title>Laryngeal Amyloidosis</dc:title>
  144.      <dc:creator>Renata M. Knoll, Peter M. Sadow, Matthew R. Naunheim</dc:creator>
  145.      <dc:identifier>10.1016/j.mayocp.2023.11.018</dc:identifier>
  146.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  147.      <dc:date>2024-03-27</dc:date>
  148.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  149.      <prism:publicationDate>2024-03-27</prism:publicationDate>
  150.      <prism:section>Medical image</prism:section>
  151.   </item>
  152.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00367-1/fulltext?rss=yes">
  153.      <title>50-Year-Old Man With Fevers, Cough, and Night Sweats</title>
  154.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00367-1/fulltext?rss=yes</link>
  155.      <description>A 50-year-old man presented to the emergency department in August with a 1-month history of progressive nonproductive cough, daily fevers, and drenching night sweats. His medical comorbidities included rheumatoid arthritis. Medications at the time of presentation included adalimumab and occasional acetaminophen as needed. He reported social alcohol use and no tobacco or recreational drug use. He endorsed intermittent headaches, mild dyspnea on exertion, several episodes of feeling off balance, and mild difficulties with short-term memory.</description>
  156.      <dc:title>50-Year-Old Man With Fevers, Cough, and Night Sweats</dc:title>
  157.      <dc:creator>Joelle N. Friesen, Alexandra Allman, Omar Abu Saleh</dc:creator>
  158.      <dc:identifier>10.1016/j.mayocp.2023.07.030</dc:identifier>
  159.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  160.      <dc:date>2024-03-27</dc:date>
  161.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  162.      <prism:publicationDate>2024-03-27</prism:publicationDate>
  163.      <prism:section>Residents’ clinic</prism:section>
  164.   </item>
  165.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00358-0/fulltext?rss=yes">
  166.      <title>Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study</title>
  167.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00358-0/fulltext?rss=yes</link>
  168.      <description>To investigate whether hypotensive patients diagnosed with heart failure and reduced ejection fraction (HFrEF) might benefit from angiotensin receptor–neprilysin inhibitors (ARNis) in real-world practice because patients with baseline systolic blood pressure (SBP) of less than 100 mm Hg have been excluded from landmark trials.</description>
  169.      <dc:title>Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study</dc:title>
  170.      <dc:creator>Chien-Yi Hsu, Fa-Po Chung, Chieh-Ju Chao, Ying-Ju Chen, Cho-Kai Wu, Yen-Wen Wu, Jin-Long Huang, Pao-Hsien Chu, Charles Jia-Yin Hou, Hung-Yu Chang, Chung-Lieh Hung</dc:creator>
  171.      <dc:identifier>10.1016/j.mayocp.2023.07.023</dc:identifier>
  172.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  173.      <dc:date>2024-03-26</dc:date>
  174.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  175.      <prism:publicationDate>2024-03-26</prism:publicationDate>
  176.      <prism:section>Original Article</prism:section>
  177.   </item>
  178.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00453-6/fulltext?rss=yes">
  179.      <title>49-Year-Old Man With Melena and Abdominal Pain</title>
  180.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00453-6/fulltext?rss=yes</link>
  181.      <description>A 49-year-old man presented with a 6-day history of melena. During this time, he also experienced progressive fatigue, light-headedness and dyspnea on exertion, nausea, and a constant epigastric abdominal pain described as a cramping sensation that was unrelated to meals. He had experienced similar symptoms 6 years previously as well as 1 month prior to the current presentation. For the latter episode, he was evaluated at a local hospital where his hemoglobin level was determined to be 4.6 g/dL (reference range, 13.2 to 16.6 g/dL) and he underwent a blood transfusion.</description>
  182.      <dc:title>49-Year-Old Man With Melena and Abdominal Pain</dc:title>
  183.      <dc:creator>Bibek Saha, Alex P. Danielson, William C. Mundell</dc:creator>
  184.      <dc:identifier>10.1016/j.mayocp.2023.09.006</dc:identifier>
  185.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  186.      <dc:date>2024-03-24</dc:date>
  187.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  188.      <prism:publicationDate>2024-03-24</prism:publicationDate>
  189.      <prism:section>Residents’ clinic</prism:section>
  190.   </item>
  191.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00412-3/fulltext?rss=yes">
  192.      <title>75-Year-Old Woman With Abdominal Distention</title>
  193.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00412-3/fulltext?rss=yes</link>
  194.      <description>A 75-year-old woman presented to the emergency department with progressive abdominal distention and pain. Her medical history includes colorectal cancer requiring left hemicolectomy and subsequent colostomy takedown 6 years before presentation at our center. She underwent open reduction with internal fixation of a right hip fracture 5 days before seeking emergency care and subsequently experienced gradual, progressive abdominal distention starting on postoperative day 1. She was passing gas and had a single small bowel movement on the day of discharge to inpatient rehabilitation.</description>
  195.      <dc:title>75-Year-Old Woman With Abdominal Distention</dc:title>
  196.      <dc:creator>Thomas Smith, James F. Howick V, Seth Sweetser</dc:creator>
  197.      <dc:identifier>10.1016/j.mayocp.2023.08.019</dc:identifier>
  198.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  199.      <dc:date>2024-03-24</dc:date>
  200.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  201.      <prism:publicationDate>2024-03-24</prism:publicationDate>
  202.      <prism:section>Residents’ clinic</prism:section>
  203.   </item>
  204.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00451-2/fulltext?rss=yes">
  205.      <title>66-Year-Old Woman With Fatigue and Hypotension</title>
  206.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00451-2/fulltext?rss=yes</link>
  207.      <description>A 66-year-old woman presented to the emergency department with progressive fatigue, weakness, diarrhea, and hypotension of 3 weeks’ duration. Her symptoms had been gradually worsening without any clear inciting event. Her medical history was notable for ileocolonic stricturing Crohn disease treated with ileocecectomy 21 years previously, Charcot-Marie-Tooth disease (CMT), obesity, osteoporosis, depression, and dyslipidemia. Her medications had included alendronate, azathioprine for her Crohn disease, and paroxetine for depression, but she had stopped taking the latter 2 medications when her current symptoms started.</description>
  208.      <dc:title>66-Year-Old Woman With Fatigue and Hypotension</dc:title>
  209.      <dc:creator>Thomas W. Fredrick, Ruth E. DeFoster</dc:creator>
  210.      <dc:identifier>10.1016/j.mayocp.2023.09.004</dc:identifier>
  211.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  212.      <dc:date>2024-03-23</dc:date>
  213.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  214.      <prism:publicationDate>2024-03-23</prism:publicationDate>
  215.      <prism:section>Residents’ clinic</prism:section>
  216.   </item>
  217.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00414-7/fulltext?rss=yes">
  218.      <title>19-Year-Old Man With Abdominal Pain, Vomiting, Bloody Diarrhea, and Rash</title>
  219.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00414-7/fulltext?rss=yes</link>
  220.      <description>A 19-year-old man presented to the emergency department with abdominal pain, bloody diarrhea, vomiting, and rash. His symptoms began 1 week prior with nausea, vomiting, and watery diarrhea. Over the next few days, he developed crampy lower abdominal pain and began noting blood in his stools. His diarrhea progressively worsened and by the time of presentation he was having 10 to 12 episodes daily, most of which were bloody. Throughout this period, he noted the appearance of scattered “bumps” over his trunk, arms, and legs.</description>
  221.      <dc:title>19-Year-Old Man With Abdominal Pain, Vomiting, Bloody Diarrhea, and Rash</dc:title>
  222.      <dc:creator>David L. Farrier, David Chiang, Amindra S. Arora</dc:creator>
  223.      <dc:identifier>10.1016/j.mayocp.2023.08.021</dc:identifier>
  224.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  225.      <dc:date>2024-03-23</dc:date>
  226.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  227.      <prism:publicationDate>2024-03-23</prism:publicationDate>
  228.      <prism:section>Residents’ clinic</prism:section>
  229.   </item>
  230.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00413-5/fulltext?rss=yes">
  231.      <title>51-Year-Old Woman With Bloody Diarrhea</title>
  232.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00413-5/fulltext?rss=yes</link>
  233.      <description>A 51-year-old woman presented to the emergency department with bloody diarrhea and abdominal cramping. Symptoms began 5 days before presentation with initially nonbloody diarrhea. She had used over-the-counter loperamide with improvement of stool frequency; however, abdominal cramping persisted. Subsequently, diarrhea became more profuse and became bloody 2 days before presentation. She denied fever or rigor. Her medical history was notable for remote deep venous thrombosis, heterozygous factor V Leiden mutation, and class II obesity with distant history of gastric bypass.</description>
  234.      <dc:title>51-Year-Old Woman With Bloody Diarrhea</dc:title>
  235.      <dc:creator>Samantha E. Mannion, Clifford M. Csizmar, Sean R. Legler</dc:creator>
  236.      <dc:identifier>10.1016/j.mayocp.2023.08.020</dc:identifier>
  237.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  238.      <dc:date>2024-03-23</dc:date>
  239.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  240.      <prism:publicationDate>2024-03-23</prism:publicationDate>
  241.      <prism:section>Residents’ clinic</prism:section>
  242.   </item>
  243.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00603-1/fulltext?rss=yes">
  244.      <title>Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality</title>
  245.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00603-1/fulltext?rss=yes</link>
  246.      <description>To assess the associations of docosahexaenoic acid (DHA), a marine omega-3 fatty acid, with long-term all-cause mortality, cardiovascular (CV) mortality, and cancer mortality.</description>
  247.      <dc:title>Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality</dc:title>
  248.      <dc:creator>Evan L. O’Keefe, James H. O’Keefe, Nathan L. Tintle, Jason Westra, Luc Albuisson, William S. Harris</dc:creator>
  249.      <dc:identifier>10.1016/j.mayocp.2023.11.026</dc:identifier>
  250.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  251.      <dc:date>2024-03-20</dc:date>
  252.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  253.      <prism:publicationDate>2024-03-20</prism:publicationDate>
  254.      <prism:volume>99</prism:volume>
  255.      <prism:number>4</prism:number>
  256.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  257.      <prism:section>Original article</prism:section>
  258.      <prism:startingPage>534</prism:startingPage>
  259.      <prism:endingPage>541</prism:endingPage>
  260.   </item>
  261.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00572-4/fulltext?rss=yes">
  262.      <title>County Rurality and Incidence and Prevalence of Diagnosed Diabetes in the United States</title>
  263.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00572-4/fulltext?rss=yes</link>
  264.      <description>To examine differences in the incidence and prevalence of diagnosed diabetes by county rurality.</description>
  265.      <dc:title>County Rurality and Incidence and Prevalence of Diagnosed Diabetes in the United States</dc:title>
  266.      <dc:creator>Sagar B. Dugani, Brian D. Lahr, Hui Xie, Michelle M. Mielke, Kent R. Bailey, Adrian Vella</dc:creator>
  267.      <dc:identifier>10.1016/j.mayocp.2023.11.022</dc:identifier>
  268.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  269.      <dc:date>2024-03-19</dc:date>
  270.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  271.      <prism:publicationDate>2024-03-19</prism:publicationDate>
  272.      <prism:section>Original article</prism:section>
  273.   </item>
  274.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00026-0/fulltext?rss=yes">
  275.      <title>High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction</title>
  276.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00026-0/fulltext?rss=yes</link>
  277.      <description>To evaluate the diagnostic performance of the previously recommended baseline high-sensitivity cardiac troponin T (hs-cTnT) thresholds of 52 and 100 ng/L in identifying patients at high risk of acute myocardial infarction (AMI).</description>
  278.      <dc:title>High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction</dc:title>
  279.      <dc:creator>Jonathan D. Knott, Olatunde Ola, Laura De Michieli, Ashok Akula, Eric H. Yang, S. Michael Gharacholou, Josh Slusser, Bradley Lewis, Ramila A. Mehta, Rajiv Gulati, Yader Sandoval, Allan S. Jaffe</dc:creator>
  280.      <dc:identifier>10.1016/j.mayocp.2023.12.019</dc:identifier>
  281.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  282.      <dc:date>2024-03-16</dc:date>
  283.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  284.      <prism:publicationDate>2024-03-16</prism:publicationDate>
  285.      <prism:section>Original article</prism:section>
  286.   </item>
  287.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00570-0/fulltext?rss=yes">
  288.      <title>Circle of Willis</title>
  289.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00570-0/fulltext?rss=yes</link>
  290.      <description>A man in his 50s with a history of squamous cell carcinoma of the tongue with cervical lymph node involvement after radiotherapy presented to an ophthalmologist with intermittent visual changes. His neurologic examination yielded normal results. Fundoscopy revealed cotton wool spots bilaterally, concerning for ischemic retinopathy. Computed tomographic angiography of the neck revealed chronic complete occlusions of the bilateral common carotid arteries and the left vertebral artery. Magnetic resonance imaging of the brain showed multiple bihemispheric watershed infarcts.</description>
  291.      <dc:title>Circle of Willis</dc:title>
  292.      <dc:creator>Nitesh P. Patel, Lorenzo Rinaldo, Giuseppe Lanzino</dc:creator>
  293.      <dc:identifier>10.1016/j.mayocp.2023.11.020</dc:identifier>
  294.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  295.      <dc:date>2024-03-07</dc:date>
  296.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  297.      <prism:publicationDate>2024-03-07</prism:publicationDate>
  298.      <prism:volume>99</prism:volume>
  299.      <prism:number>4</prism:number>
  300.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  301.      <prism:section>Medical image</prism:section>
  302.      <prism:startingPage>677</prism:startingPage>
  303.      <prism:endingPage>678</prism:endingPage>
  304.   </item>
  305.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00480-9/fulltext?rss=yes">
  306.      <title>Congenital Absence of Right Coronary Artery</title>
  307.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00480-9/fulltext?rss=yes</link>
  308.      <description>A White male in his 20s with no past medical history presented with sudden symptoms of shortness of breath, nausea, and vomiting while at work. He also had a fever, cough, and tested positive for cannabis and tetrahydrocannabinol. On admission, he showed sinus tachycardia at 150 beats/min and low blood pressure (112/52 mm Hg). Laboratory tests revealed abnormal results, including elevated white blood cell count (24×109/L [reference range, &lt;3.4×109/L]) and troponin T levels (670 ng/L [reference range, ≤15×109/L]).</description>
  309.      <dc:title>Congenital Absence of Right Coronary Artery</dc:title>
  310.      <dc:creator>Shriya Sharma, Elizabeth Johnson, Rohan Goswami</dc:creator>
  311.      <dc:identifier>10.1016/j.mayocp.2023.10.008</dc:identifier>
  312.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  313.      <dc:date>2024-03-07</dc:date>
  314.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  315.      <prism:publicationDate>2024-03-07</prism:publicationDate>
  316.      <prism:volume>99</prism:volume>
  317.      <prism:number>4</prism:number>
  318.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  319.      <prism:section>Medical image</prism:section>
  320.      <prism:startingPage>527</prism:startingPage>
  321.      <prism:endingPage>528</prism:endingPage>
  322.   </item>
  323.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00359-2/fulltext?rss=yes">
  324.      <title>Outcomes of Acute Respiratory Failure in Patients With Cancer in the United States</title>
  325.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00359-2/fulltext?rss=yes</link>
  326.      <description>To determine the epidemiological effect-magnitude and outcomes of patients with cancer vs those without cancer who are hospitalized with acute respiratory failure (ARF).</description>
  327.      <dc:title>Outcomes of Acute Respiratory Failure in Patients With Cancer in the United States</dc:title>
  328.      <dc:creator>Kiyan Heybati, Jiawen Deng, Archis Bhandarkar, Fangwen Zhou, Cameron Zamanian, Namrata Arya, Mohamad Bydon, Philippe R. Bauer, Ognjen Gajic, Allan J. Walkey, Hemang Yadav</dc:creator>
  329.      <dc:identifier>10.1016/j.mayocp.2023.07.024</dc:identifier>
  330.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  331.      <dc:date>2024-03-07</dc:date>
  332.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  333.      <prism:publicationDate>2024-03-07</prism:publicationDate>
  334.      <prism:volume>99</prism:volume>
  335.      <prism:number>4</prism:number>
  336.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  337.      <prism:section>Original article</prism:section>
  338.      <prism:startingPage>578</prism:startingPage>
  339.      <prism:endingPage>592</prism:endingPage>
  340.   </item>
  341.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00341-5/fulltext?rss=yes">
  342.      <title>Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery</title>
  343.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00341-5/fulltext?rss=yes</link>
  344.      <description>To explore admission and discharge prescription rates of guideline-directed medical therapy (GDMT), defined as aggregate antiplatelet agents, statins, and β-blockers, after coronary artery bypass graft (CABG) surgery and to reveal its association with long-term survival.</description>
  345.      <dc:title>Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery</dc:title>
  346.      <dc:creator>Yaron Moshkovitz, Liat Orenstein, Liraz Olmer, Keren Laufer, Arnona Ziv, Rachel Dankner</dc:creator>
  347.      <dc:identifier>10.1016/j.mayocp.2023.06.022</dc:identifier>
  348.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  349.      <dc:date>2024-03-06</dc:date>
  350.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  351.      <prism:publicationDate>2024-03-06</prism:publicationDate>
  352.      <prism:section>Original article</prism:section>
  353.   </item>
  354.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00365-8/fulltext?rss=yes">
  355.      <title>34-Year-Old Man With Sudden Epigastric Abdominal Pain</title>
  356.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00365-8/fulltext?rss=yes</link>
  357.      <description>A 34-year-old man with a history of multiple episodes of acute pancreatitis complicated by known pseudocysts, fatty liver disease, and polysubstance abuse presented to the emergency department with sudden onset of epigastric abdominal pain, nausea, and vomiting. His symptoms started approximately 45 minutes after eating dinner. He was not taking any medications and denied recent trauma. The patient reported active smoking (19 pack-year history) and consumption of several alcoholic drinks earlier that day.</description>
  358.      <dc:title>34-Year-Old Man With Sudden Epigastric Abdominal Pain</dc:title>
  359.      <dc:creator>Caroline G. Olson, Christian Karime, Razvan Chirila</dc:creator>
  360.      <dc:identifier>10.1016/j.mayocp.2023.07.028</dc:identifier>
  361.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  362.      <dc:date>2024-02-06</dc:date>
  363.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  364.      <prism:publicationDate>2024-02-06</prism:publicationDate>
  365.      <prism:volume>99</prism:volume>
  366.      <prism:number>4</prism:number>
  367.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  368.      <prism:section>Residents’ clinic</prism:section>
  369.      <prism:startingPage>649</prism:startingPage>
  370.      <prism:endingPage>654</prism:endingPage>
  371.   </item>
  372.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00364-6/fulltext?rss=yes">
  373.      <title>40-Year-Old Woman Presenting With Heartburn</title>
  374.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00364-6/fulltext?rss=yes</link>
  375.      <description>A 40-year-old woman presented to the outpatient clinic with a 3-month history of worsening heartburn and regurgitation. Symptoms occurred nearly daily, were worse after spicy foods and carbonated beverages, and were relieved by calcium carbonate. She had no associated fever, weight loss, changes in bowel habits, or dysphagia. She had never traveled internationally. Her medical history was notable only for bipolar I disorder well controlled with lithium and quetiapine. She had no history of abdominal surgery or tobacco use, and she consumed 4 ounces of wine 3 to 4 times per week.</description>
  376.      <dc:title>40-Year-Old Woman Presenting With Heartburn</dc:title>
  377.      <dc:creator>Lauren Loeb, Andree H. Koop</dc:creator>
  378.      <dc:identifier>10.1016/j.mayocp.2023.07.027</dc:identifier>
  379.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  380.      <dc:date>2024-02-06</dc:date>
  381.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  382.      <prism:publicationDate>2024-02-06</prism:publicationDate>
  383.      <prism:volume>99</prism:volume>
  384.      <prism:number>4</prism:number>
  385.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  386.      <prism:section>Residents’ clinic</prism:section>
  387.      <prism:startingPage>655</prism:startingPage>
  388.      <prism:endingPage>660</prism:endingPage>
  389.   </item>
  390.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00469-X/fulltext?rss=yes">
  391.      <title>Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality</title>
  392.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00469-X/fulltext?rss=yes</link>
  393.      <description>To determine whether body composition derived from medical imaging may be useful for assessing biologic age at the tissue level because people of the same chronologic age may vary with respect to their biologic age.</description>
  394.      <dc:title>Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality</dc:title>
  395.      <dc:creator>Andrew D. Rule, Brandon R. Grossardt, Alexander D. Weston, Hillary W. Garner, Timothy L. Kline, Alanna M. Chamberlain, Alina M. Allen, Bradley J. Erickson, Walter A. Rocca, Jennifer L. St. Sauver</dc:creator>
  396.      <dc:identifier>10.1016/j.mayocp.2023.09.021</dc:identifier>
  397.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  398.      <dc:date>2024-02-02</dc:date>
  399.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  400.      <prism:publicationDate>2024-02-02</prism:publicationDate>
  401.      <prism:section>Original article</prism:section>
  402.   </item>
  403.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00407-X/fulltext?rss=yes">
  404.      <title>Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy</title>
  405.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00407-X/fulltext?rss=yes</link>
  406.      <description>To report the clinicopathologic characteristics, prognostic indicators, prognosis, and transplant outcome of secondary oxalate nephropathy (ON).</description>
  407.      <dc:title>Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy</dc:title>
  408.      <dc:creator>Samih H. Nasr, Anthony M. Valeri, Samar M. Said, Sanjeev Sethi, Karl A. Nath, John C. Lieske, Lihong Bu</dc:creator>
  409.      <dc:identifier>10.1016/j.mayocp.2023.08.014</dc:identifier>
  410.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  411.      <dc:date>2024-02-01</dc:date>
  412.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  413.      <prism:publicationDate>2024-02-01</prism:publicationDate>
  414.      <prism:volume>99</prism:volume>
  415.      <prism:number>4</prism:number>
  416.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  417.      <prism:section>Original article</prism:section>
  418.      <prism:startingPage>593</prism:startingPage>
  419.      <prism:endingPage>606</prism:endingPage>
  420.   </item>
  421.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00366-X/fulltext?rss=yes">
  422.      <title>22-Year-Old Man With Seizures</title>
  423.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00366-X/fulltext?rss=yes</link>
  424.      <description>A 22-year-old man presented to the emergency department (ED) because of recurrent seizures. His medical comorbidities included epilepsy, type 1 diabetes mellitus, and recently diagnosed Hashimoto thyroiditis. His medications included lacosamide, insulin through an insulin pump, and levothyroxine.</description>
  425.      <dc:title>22-Year-Old Man With Seizures</dc:title>
  426.      <dc:creator>Priscilla Koirala, Reema K. Tawfiq, David Raslau</dc:creator>
  427.      <dc:identifier>10.1016/j.mayocp.2023.07.029</dc:identifier>
  428.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  429.      <dc:date>2024-01-31</dc:date>
  430.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  431.      <prism:publicationDate>2024-01-31</prism:publicationDate>
  432.      <prism:volume>99</prism:volume>
  433.      <prism:number>4</prism:number>
  434.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  435.      <prism:section>Residents’ clinic</prism:section>
  436.      <prism:startingPage>661</prism:startingPage>
  437.      <prism:endingPage>664</prism:endingPage>
  438.   </item>
  439.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00304-X/fulltext?rss=yes">
  440.      <title>Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation</title>
  441.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00304-X/fulltext?rss=yes</link>
  442.      <description>To compare outcomes after left atrial appendage occlusion (LAAO) via implanted device vs no LAAO in a matched cohort of patients with atrial fibrillation (AF).</description>
  443.      <dc:title>Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation</dc:title>
  444.      <dc:creator>Baptiste Maille, Pascal Defaye, Sid Ahmed Bentounes, Julien Herbert, Jean Michel Clerc, Bertrand Pierre, Olivier Torras, Jean Claude Deharo, Laurent Fauchier</dc:creator>
  445.      <dc:identifier>10.1016/j.mayocp.2023.05.030</dc:identifier>
  446.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
  447.      <dc:date>2024-01-04</dc:date>
  448.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  449.      <prism:publicationDate>2024-01-04</prism:publicationDate>
  450.      <prism:section>Original Article</prism:section>
  451.   </item>
  452.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00356-7/fulltext?rss=yes">
  453.      <title>Hospital Outcomes in Medical Patients With Alcohol-Related and Non–Alcohol-Related Wernicke Encephalopathy</title>
  454.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00356-7/fulltext?rss=yes</link>
  455.      <description>To conduct a nationwide retrospective cohort study to assess trends and hospitalization-associated outcomes in patients with Wernicke encephalopathy.</description>
  456.      <dc:title>Hospital Outcomes in Medical Patients With Alcohol-Related and Non–Alcohol-Related Wernicke Encephalopathy</dc:title>
  457.      <dc:creator>Roshaani Rasiah, Claudia Gregoriano, Beat Mueller, Alexander Kutz, Philipp Schuetz</dc:creator>
  458.      <dc:identifier>10.1016/j.mayocp.2023.07.021</dc:identifier>
  459.      <dc:source>Mayo Clinic Proceedings (2023)</dc:source>
  460.      <dc:date>2023-12-08</dc:date>
  461.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  462.      <prism:publicationDate>2023-12-08</prism:publicationDate>
  463.      <prism:section>Original article</prism:section>
  464.   </item>
  465.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00373-7/fulltext?rss=yes">
  466.      <title>Shock Severity Classification and Mortality in Adults With Cardiac, Medical, Surgical, and Neurological Critical Illness</title>
  467.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00373-7/fulltext?rss=yes</link>
  468.      <description>To evaluate whether the Society for Cardiovascular Angiography and Interventions (SCAI) Shock Classification could perform risk stratification in a mixed cohort of intensive care unit (ICU) patients, similar to its validation in patients with acute cardiac disease.</description>
  469.      <dc:title>Shock Severity Classification and Mortality in Adults With Cardiac, Medical, Surgical, and Neurological Critical Illness</dc:title>
  470.      <dc:creator>Jacob C. Jentzer, Devang Senghavi, Parag C. Patel, Anirban Bhattacharyya, Sean van Diepen, Vitaly Herasevich, Ognjen Gajic, Kianoush B. Kashani</dc:creator>
  471.      <dc:identifier>10.1016/j.mayocp.2023.08.007</dc:identifier>
  472.      <dc:source>Mayo Clinic Proceedings (2023)</dc:source>
  473.      <dc:date>2023-10-08</dc:date>
  474.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  475.      <prism:publicationDate>2023-10-08</prism:publicationDate>
  476.      <prism:section>Original article</prism:section>
  477.   </item>
  478.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00283-5/fulltext?rss=yes">
  479.      <title>Physical Activity and Cause-Specific Cardiovascular Mortality Among People With and Without Cardiovascular Disease: A Cohort Study of 0.6 Million US Adults</title>
  480.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00283-5/fulltext?rss=yes</link>
  481.      <description>To assess the association of physical activity (PA) with cause-specific cardiovascular disease (CVD) mortality among people with preexisting CVD and to analyze the relationship of PA with CVD-related mortality in people without CVD as well as the association of PA with nonspecific CVD mortality in both populations.</description>
  482.      <dc:title>Physical Activity and Cause-Specific Cardiovascular Mortality Among People With and Without Cardiovascular Disease: A Cohort Study of 0.6 Million US Adults</dc:title>
  483.      <dc:creator>Verónica Cabanas-Sánchez, Miguel Angelo Duarte Junior, Carl J. Lavie, Carlos Celis-Morales, Fernando Rodríguez-Artalejo, David Martínez-Gómez</dc:creator>
  484.      <dc:identifier>10.1016/j.mayocp.2023.05.028</dc:identifier>
  485.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  486.      <dc:date>2023-09-05</dc:date>
  487.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  488.      <prism:publicationDate>2023-09-05</prism:publicationDate>
  489.      <prism:volume>99</prism:volume>
  490.      <prism:number>4</prism:number>
  491.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  492.      <prism:section>Original article</prism:section>
  493.      <prism:startingPage>564</prism:startingPage>
  494.      <prism:endingPage>577</prism:endingPage>
  495.   </item>
  496.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00347-6/fulltext?rss=yes">
  497.      <title>Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry</title>
  498.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00347-6/fulltext?rss=yes</link>
  499.      <description>To explore the association between metabolic status, body mass index (BMI), and natural history of patients with atrial fibrillation (AF).</description>
  500.      <dc:title>Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry</dc:title>
  501.      <dc:creator>Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Davide Antonio Mei, Giuseppe Boriani, Tze-Fan Chao, Brian Olshansky, Menno V. Huisman, Gregory Y.H. Lip, GLORIA-AF Investigators</dc:creator>
  502.      <dc:identifier>10.1016/j.mayocp.2023.07.013</dc:identifier>
  503.      <dc:source>Mayo Clinic Proceedings (2023)</dc:source>
  504.      <dc:date>2023-08-25</dc:date>
  505.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  506.      <prism:publicationDate>2023-08-25</prism:publicationDate>
  507.      <prism:section>Original Article</prism:section>
  508.   </item>
  509.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00305-1/fulltext?rss=yes">
  510.      <title>Association of a Mediterranean Lifestyle With All-Cause and Cause-Specific Mortality: A Prospective Study from the UK Biobank</title>
  511.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00305-1/fulltext?rss=yes</link>
  512.      <description>To examine the association between the Mediterranean lifestyle and all-cause, cancer, and cardiovascular disease (CVD) mortality in a British population.</description>
  513.      <dc:title>Association of a Mediterranean Lifestyle With All-Cause and Cause-Specific Mortality: A Prospective Study from the UK Biobank</dc:title>
  514.      <dc:creator>Javier Maroto-Rodriguez, Mario Delgado-Velandia, Rosario Ortolá, Aurora Perez-Cornago, Stefanos N. Kales, Fernando Rodríguez-Artalejo, Mercedes Sotos-Prieto</dc:creator>
  515.      <dc:identifier>10.1016/j.mayocp.2023.05.031</dc:identifier>
  516.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  517.      <dc:date>2023-08-16</dc:date>
  518.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  519.      <prism:publicationDate>2023-08-16</prism:publicationDate>
  520.      <prism:volume>99</prism:volume>
  521.      <prism:number>4</prism:number>
  522.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  523.      <prism:section>Original article</prism:section>
  524.      <prism:startingPage>551</prism:startingPage>
  525.      <prism:endingPage>563</prism:endingPage>
  526.   </item>
  527.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00144-7/fulltext?rss=yes">
  528.      <title>Highlights From the Current Issue – Audiovisual Summary</title>
  529.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00144-7/fulltext?rss=yes</link>
  530.      <description>Karl A. Nath, MBChB, Editor-in-Chief of Mayo Clinic Proceedings, discusses the Editor’s Choice and Highlights articles appearing in the April 2024 issue.</description>
  531.      <dc:title>Highlights From the Current Issue – Audiovisual Summary</dc:title>
  532.      <dc:creator>Karl A. Nath</dc:creator>
  533.      <dc:identifier>10.1016/j.mayocp.2024.03.008</dc:identifier>
  534.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  535.      <dc:date>2024-04</dc:date>
  536.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  537.      <prism:publicationDate>2024-04</prism:publicationDate>
  538.      <prism:volume>99</prism:volume>
  539.      <prism:number>4</prism:number>
  540.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  541.      <prism:section>Issue summary</prism:section>
  542.      <prism:startingPage>e1</prism:startingPage>
  543.   </item>
  544.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00112-5/fulltext?rss=yes">
  545.      <title>General Information</title>
  546.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00112-5/fulltext?rss=yes</link>
  547.      <dc:title>General Information</dc:title>
  548.      <dc:identifier>10.1016/S0025-6196(24)00112-5</dc:identifier>
  549.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  550.      <dc:date>2024-04</dc:date>
  551.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  552.      <prism:publicationDate>2024-04</prism:publicationDate>
  553.      <prism:volume>99</prism:volume>
  554.      <prism:number>4</prism:number>
  555.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  556.      <prism:startingPage>A6</prism:startingPage>
  557.   </item>
  558.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00111-3/fulltext?rss=yes">
  559.      <title>Table of Contents</title>
  560.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00111-3/fulltext?rss=yes</link>
  561.      <dc:title>Table of Contents</dc:title>
  562.      <dc:identifier>10.1016/S0025-6196(24)00111-3</dc:identifier>
  563.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  564.      <dc:date>2024-04</dc:date>
  565.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  566.      <prism:publicationDate>2024-04</prism:publicationDate>
  567.      <prism:volume>99</prism:volume>
  568.      <prism:number>4</prism:number>
  569.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  570.      <prism:startingPage>A3</prism:startingPage>
  571.      <prism:endingPage>A5</prism:endingPage>
  572.   </item>
  573.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00110-1/fulltext?rss=yes">
  574.      <title>Editorial Board</title>
  575.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00110-1/fulltext?rss=yes</link>
  576.      <dc:title>Editorial Board</dc:title>
  577.      <dc:identifier>10.1016/S0025-6196(24)00110-1</dc:identifier>
  578.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  579.      <dc:date>2024-04</dc:date>
  580.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  581.      <prism:publicationDate>2024-04</prism:publicationDate>
  582.      <prism:volume>99</prism:volume>
  583.      <prism:number>4</prism:number>
  584.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  585.      <prism:startingPage>A1</prism:startingPage>
  586.      <prism:endingPage>A2</prism:endingPage>
  587.   </item>
  588.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00103-4/fulltext?rss=yes">
  589.      <title>In the Limelight: April 2024</title>
  590.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00103-4/fulltext?rss=yes</link>
  591.      <description>This month’s feature highlights three articles that appear in the current issue of Mayo Clinic Proceedings. These articles are also featured on the Mayo Clinic Proceedings’ YouTube Channel (https://youtu.be/9emMAR65ZTo).</description>
  592.      <dc:title>In the Limelight: April 2024</dc:title>
  593.      <dc:creator>Karl A. Nath</dc:creator>
  594.      <dc:identifier>10.1016/j.mayocp.2024.02.017</dc:identifier>
  595.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  596.      <dc:date>2024-04</dc:date>
  597.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  598.      <prism:publicationDate>2024-04</prism:publicationDate>
  599.      <prism:volume>99</prism:volume>
  600.      <prism:number>4</prism:number>
  601.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  602.      <prism:section>In the limelight</prism:section>
  603.      <prism:startingPage>517</prism:startingPage>
  604.      <prism:endingPage>519</prism:endingPage>
  605.   </item>
  606.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00102-2/fulltext?rss=yes">
  607.      <title>Is Medical Cannabis a Solution for Controlling Fibromyalgia Symptoms?</title>
  608.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00102-2/fulltext?rss=yes</link>
  609.      <description>Fibromyalgia syndrome (FMS) represents a complex chronic pain disorder primarily characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive impairment. Because of the complexities it entails, FMS is also manifested with significant challenges in diagnosis and management. Despite numerous approved pharmacologic and nonpharmacologic interventions, the clinical outcomes of patients with FMS remain suboptimal, prompting exploration into new therapeutic modalities.</description>
  610.      <dc:title>Is Medical Cannabis a Solution for Controlling Fibromyalgia Symptoms?</dc:title>
  611.      <dc:creator>Paula David, Aia Mohsen, Howard Amital</dc:creator>
  612.      <dc:identifier>10.1016/j.mayocp.2024.02.016</dc:identifier>
  613.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  614.      <dc:date>2024-04</dc:date>
  615.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  616.      <prism:publicationDate>2024-04</prism:publicationDate>
  617.      <prism:volume>99</prism:volume>
  618.      <prism:number>4</prism:number>
  619.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  620.      <prism:section>Editorial</prism:section>
  621.      <prism:startingPage>524</prism:startingPage>
  622.      <prism:endingPage>526</prism:endingPage>
  623.   </item>
  624.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00101-0/fulltext?rss=yes">
  625.      <title>Bringing the Potential Benefits of Omega-3 to a Higher Level</title>
  626.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00101-0/fulltext?rss=yes</link>
  627.      <description>Eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, the main long-chain omega-3 polyunsaturated fatty acids present in seafood, have been proposed for use in the prevention and treatment of cardiovascular diseases (CVDs). Diet is the primary source of protective fatty acids, but personal preferences and dietary restrictions, among other factors, can prevent people from eating a sufficient amount of food rich in EPA and DHA, so adequate intake of omega-3 fatty acids is not always achieved. Therefore, the use of omega-3 supplements containing EPA and DHA can be recommended to increase EPA and DHA to the appropriate levels.</description>
  628.      <dc:title>Bringing the Potential Benefits of Omega-3 to a Higher Level</dc:title>
  629.      <dc:creator>Jari A. Laukkanen, Aldo A. Bernasconi, Carl J. Lavie</dc:creator>
  630.      <dc:identifier>10.1016/j.mayocp.2024.02.015</dc:identifier>
  631.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  632.      <dc:date>2024-04</dc:date>
  633.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  634.      <prism:publicationDate>2024-04</prism:publicationDate>
  635.      <prism:volume>99</prism:volume>
  636.      <prism:number>4</prism:number>
  637.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  638.      <prism:section>Editorial</prism:section>
  639.      <prism:startingPage>520</prism:startingPage>
  640.      <prism:endingPage>523</prism:endingPage>
  641.   </item>
  642.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00098-3/fulltext?rss=yes">
  643.      <title>Rainbow Trout # 5, Brook Trout # 2, Rockfish # 5, Walley # 5 by Bonnie Murray</title>
  644.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00098-3/fulltext?rss=yes</link>
  645.      <description>Art is integrated into the Mayo Clinic environment. Since the original Mayo Clinic Building was finished in 1914, many pieces have been donated or commissioned for patients and staff to enjoy. Each issue of Mayo Clinic Proceedings features a work of art (as interpreted by the author) that is displayed in a building or on the grounds of Mayo Clinic campuses.</description>
  646.      <dc:title>Rainbow Trout # 5, Brook Trout # 2, Rockfish # 5, Walley # 5 by Bonnie Murray</dc:title>
  647.      <dc:creator>Margaret R. Wentz</dc:creator>
  648.      <dc:identifier>10.1016/j.mayocp.2024.02.014</dc:identifier>
  649.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  650.      <dc:date>2024-04</dc:date>
  651.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  652.      <prism:publicationDate>2024-04</prism:publicationDate>
  653.      <prism:volume>99</prism:volume>
  654.      <prism:number>4</prism:number>
  655.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  656.      <prism:section>Art at mayo clinic</prism:section>
  657.      <prism:startingPage>683</prism:startingPage>
  658.      <prism:endingPage>684</prism:endingPage>
  659.   </item>
  660.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00097-1/fulltext?rss=yes">
  661.      <title>Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma</title>
  662.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00097-1/fulltext?rss=yes</link>
  663.      <description>A woman in her late 50s presented with pelvic pain and on transvaginal ultrasound examination was noted to have a bladder mass. Cystoscopy revealed the presence of a 6.0-cm mass, which was resected. Histopathologic examination revealed the presence of a glandular neoplasm underlying the surface urothelium (Figure 1A, B). No evidence of a precursor urothelial neoplasm, such as urothelial carcinoma in situ or papillary urothelial carcinoma, was identified.</description>
  664.      <dc:title>Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma</dc:title>
  665.      <dc:creator>Burak Tekin, Lori A. Erickson, Sounak Gupta</dc:creator>
  666.      <dc:identifier>10.1016/j.mayocp.2024.02.013</dc:identifier>
  667.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  668.      <dc:date>2024-04</dc:date>
  669.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  670.      <prism:publicationDate>2024-04</prism:publicationDate>
  671.      <prism:volume>99</prism:volume>
  672.      <prism:number>4</prism:number>
  673.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  674.      <prism:section>Path to patient image quiz</prism:section>
  675.      <prism:startingPage>680</prism:startingPage>
  676.      <prism:endingPage>682</prism:endingPage>
  677.   </item>
  678.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00084-3/fulltext?rss=yes">
  679.      <title>Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists</title>
  680.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00084-3/fulltext?rss=yes</link>
  681.      <description>Eosinophilic esophagitis (EoE) is a chronic and progressive immune-mediated esophageal disorder. Given its increasing incidence, it is now a leading cause of dysphagia and food impaction in the United States. Eosinophilic esophagitis is most common in adult White men and has a high concurrence rate with other atopic conditions like allergic rhinitis, bronchial asthma, and eczema. The initial presentation includes symptoms of esophageal dysfunction, classically solid-food dysphagia. Without treatment, inflammation can progress to fibrosis with the formation of strictures, leading to complications such as food impaction.</description>
  682.      <dc:title>Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists</dc:title>
  683.      <dc:creator>Rohit Goyal, Amrit K. Kamboj, Diana L. Snyder</dc:creator>
  684.      <dc:identifier>10.1016/j.mayocp.2023.12.026</dc:identifier>
  685.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  686.      <dc:date>2024-04</dc:date>
  687.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  688.      <prism:publicationDate>2024-04</prism:publicationDate>
  689.      <prism:volume>99</prism:volume>
  690.      <prism:number>4</prism:number>
  691.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  692.      <prism:section>Concise Review</prism:section>
  693.      <prism:startingPage>640</prism:startingPage>
  694.      <prism:endingPage>648</prism:endingPage>
  695.   </item>
  696.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00050-8/fulltext?rss=yes">
  697.      <title>The Imperative of Clinical Trial Diversity: Lessons From the SARS-CoV-2 Pandemic</title>
  698.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00050-8/fulltext?rss=yes</link>
  699.      <description>The National Academy of Science, Engineering, and Medicine recently published a report on the lack of diversity in clinical trials.1 This concern, highlighting the importance of research equity, proved especially relevant during the COVID-19 pandemic.</description>
  700.      <dc:title>The Imperative of Clinical Trial Diversity: Lessons From the SARS-CoV-2 Pandemic</dc:title>
  701.      <dc:creator>Amanda Sinderovsky, Eli Y. Adashi</dc:creator>
  702.      <dc:identifier>10.1016/j.mayocp.2024.01.014</dc:identifier>
  703.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  704.      <dc:date>2024-04</dc:date>
  705.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  706.      <prism:publicationDate>2024-04</prism:publicationDate>
  707.      <prism:volume>99</prism:volume>
  708.      <prism:number>4</prism:number>
  709.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  710.      <prism:section>Letter to the Editor</prism:section>
  711.      <prism:startingPage>679</prism:startingPage>
  712.   </item>
  713.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00034-X/fulltext?rss=yes">
  714.      <title>Vitamin D Supplementation: To D or Not to D?</title>
  715.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00034-X/fulltext?rss=yes</link>
  716.      <description>Vitamin D was once considered a panacea for a variety of ailments but now is considered by some to be unimportant. As is often the case, the pendulum swings widely from one extreme to the other.</description>
  717.      <dc:title>Vitamin D Supplementation: To D or Not to D?</dc:title>
  718.      <dc:creator>Robert Joseph Fakheri</dc:creator>
  719.      <dc:identifier>10.1016/j.mayocp.2024.01.003</dc:identifier>
  720.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  721.      <dc:date>2024-04</dc:date>
  722.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  723.      <prism:publicationDate>2024-04</prism:publicationDate>
  724.      <prism:volume>99</prism:volume>
  725.      <prism:number>4</prism:number>
  726.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  727.      <prism:section>Commentary</prism:section>
  728.      <prism:startingPage>529</prism:startingPage>
  729.      <prism:endingPage>533</prism:endingPage>
  730.   </item>
  731.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00025-9/fulltext?rss=yes">
  732.      <title>A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management</title>
  733.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00025-9/fulltext?rss=yes</link>
  734.      <description>To assess the use of cannabis as a symptom management strategy for patients with fibromyalgia.</description>
  735.      <dc:title>A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management</dc:title>
  736.      <dc:creator>Abhinav Singla, Christopher V. Anstine, Linda Huang, Jordan K. Rosedahl, Arya B. Mohabbat, Lindsey M. Philpot</dc:creator>
  737.      <dc:identifier>10.1016/j.mayocp.2023.12.018</dc:identifier>
  738.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  739.      <dc:date>2024-04</dc:date>
  740.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  741.      <prism:publicationDate>2024-04</prism:publicationDate>
  742.      <prism:volume>99</prism:volume>
  743.      <prism:number>4</prism:number>
  744.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  745.      <prism:section>Original article</prism:section>
  746.      <prism:startingPage>542</prism:startingPage>
  747.      <prism:endingPage>550</prism:endingPage>
  748.   </item>
  749.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00607-9/fulltext?rss=yes">
  750.      <title>Breast Cancer Screening Recommendations for Transgender Patients: A Review</title>
  751.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00607-9/fulltext?rss=yes</link>
  752.      <description>Shifting societal attitudes trending toward increased acceptance of transgender people has contributed to a growth in the population of individuals who openly identify as transgender as well as an increase in utilization of gender-affirming surgeries. Therefore, health care providers should work toward increasing their knowledge with respect to the health care needs of the transgender population, particularly given that these individuals often face discrimination in the health care system. Moreover, transgender breast cancer screening rates lag behind breast cancer screening rates for cisgender individuals.</description>
  753.      <dc:title>Breast Cancer Screening Recommendations for Transgender Patients: A Review</dc:title>
  754.      <dc:creator>Alex Suarez, Julia Bisschops, Katharine Lampen-Sachar</dc:creator>
  755.      <dc:identifier>10.1016/j.mayocp.2023.12.006</dc:identifier>
  756.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  757.      <dc:date>2024-04</dc:date>
  758.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  759.      <prism:publicationDate>2024-04</prism:publicationDate>
  760.      <prism:volume>99</prism:volume>
  761.      <prism:number>4</prism:number>
  762.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  763.      <prism:section>Review</prism:section>
  764.      <prism:startingPage>630</prism:startingPage>
  765.      <prism:endingPage>639</prism:endingPage>
  766.   </item>
  767.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00554-2/fulltext?rss=yes">
  768.      <title>Pemphigus Vulgaris</title>
  769.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00554-2/fulltext?rss=yes</link>
  770.      <description>A man in his mid-40s was referred with a 2-week history of painful erosions in his mouth followed by spontaneous fragile blisters on his trunk and extremities, resulting in painful erosions. Physical examination demonstrated oral lesions, widespread skin erosions, crusted lesions, and flaccid bullae over his body (Figure 1).</description>
  771.      <dc:title>Pemphigus Vulgaris</dc:title>
  772.      <dc:creator>Nika Kianfar, Maryam Daneshpazhooh, Julia S. Lehman</dc:creator>
  773.      <dc:identifier>10.1016/j.mayocp.2023.11.006</dc:identifier>
  774.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  775.      <dc:date>2024-04</dc:date>
  776.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  777.      <prism:publicationDate>2024-04</prism:publicationDate>
  778.      <prism:volume>99</prism:volume>
  779.      <prism:number>4</prism:number>
  780.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  781.      <prism:section>Medical image</prism:section>
  782.      <prism:startingPage>607</prism:startingPage>
  783.      <prism:endingPage>609</prism:endingPage>
  784.   </item>
  785.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00527-X/fulltext?rss=yes">
  786.      <title>State of Gene Therapy for Monogenic Cardiovascular Diseases</title>
  787.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00527-X/fulltext?rss=yes</link>
  788.      <description>Over the past 2 decades, significant efforts have been made to advance gene therapy into clinical practice. Although successful examples exist in other fields, gene therapy for the treatment of monogenic cardiovascular diseases lags behind. In this review, we (1) highlight a brief history of gene therapy, (2) distinguish between gene silencing, gene replacement, and gene editing technologies, (3) discuss vector modalities used in the field with a special focus on adeno-associated viruses, (4) provide examples of gene therapy approaches in cardiomyopathies, channelopathies, and familial hypercholesterolemia, and (5) present current challenges and limitations in the gene therapy field.</description>
  789.      <dc:title>State of Gene Therapy for Monogenic Cardiovascular Diseases</dc:title>
  790.      <dc:creator>Sahej Bains, John R. Giudicessi, Katja E. Odening, Michael J. Ackerman</dc:creator>
  791.      <dc:identifier>10.1016/j.mayocp.2023.11.003</dc:identifier>
  792.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  793.      <dc:date>2024-04</dc:date>
  794.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  795.      <prism:publicationDate>2024-04</prism:publicationDate>
  796.      <prism:volume>99</prism:volume>
  797.      <prism:number>4</prism:number>
  798.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  799.      <prism:section>Review</prism:section>
  800.      <prism:startingPage>610</prism:startingPage>
  801.      <prism:endingPage>629</prism:endingPage>
  802.   </item>
  803.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00061-7/fulltext?rss=yes">
  804.      <title>Advancing Translation of Clinical Research Into Practice and Population Health Impact Through Implementation Science</title>
  805.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00061-7/fulltext?rss=yes</link>
  806.      <description>Translational and implementation sciences aim to prioritize and guide efforts to create greater efficiency and speed of scientific innovation across the translational science continuum to improve patient and population health. Key principles and practices rooted in translational and implementation science may be incorporated into clinical trials research, particularly pragmatic trials, to improve the relevance and impact of scientific innovation. This thematic review intends to raise awareness on the value of translational and implementation science in clinical research and to encourage its use in designing and implementing clinical trials across the translational research continuum.</description>
  807.      <dc:title>Advancing Translation of Clinical Research Into Practice and Population Health Impact Through Implementation Science</dc:title>
  808.      <dc:creator>Lila J. Finney Rutten, Jennifer L. Ridgeway, Joan M. Griffin</dc:creator>
  809.      <dc:identifier>10.1016/j.mayocp.2023.02.005</dc:identifier>
  810.      <dc:source>Mayo Clinic Proceedings 99, 4 (2024)</dc:source>
  811.      <dc:date>2024-04</dc:date>
  812.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  813.      <prism:publicationDate>2024-04</prism:publicationDate>
  814.      <prism:volume>99</prism:volume>
  815.      <prism:number>4</prism:number>
  816.      <prism:issueIdentifier>S0025-6196(24)X0004-X</prism:issueIdentifier>
  817.      <prism:section>Thematic Review on Forward Thinking on Clinical Trials in Clinical Practice</prism:section>
  818.      <prism:startingPage>665</prism:startingPage>
  819.      <prism:endingPage>676</prism:endingPage>
  820.   </item>
  821. </rdf:RDF>
  822.  

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

  1. Download the "valid RSS" banner.

  2. Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)

  3. Add this HTML to your page (change the image src attribute if necessary):

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=http%3A//www.mayoclinicproceedings.org/current.rss

Home · About · News · Docs · Terms

 
Copyright © 2002-9 Sam Ruby, Mark Pilgrim, Joseph Walton, and Phil Ringnalda